The independent source for health policy research, polling, and news.
261-280 of 678 results
Many cases of vaping-related injury seem to involve THC, health officials say. That's led some states to take another look at the safety of the regulated cannabis market, as well as the black market.
The calming techniques that officers learn during training to intervene in a mental health crisis don't seem to work as well when a suspect is high on meth. Meth calls can be much more dangerous, police say.
Starting to vape is easy, but quitting a nicotine habit can be tough, teens are finding. Some vaping cessation programs have begun to reach out to teens where they live — on their phones.
A few hundred hospitals have banded together to sue drugmakers in state courts, but far more are staying on the sidelines to avoid 'unflattering attention' about their role in the opioid crisis.
One in 4 high school seniors report vaping in the previous month. Teens talk about how quickly vaping became ingrained in teen culture and how hard it is to quit vaping nicotine.
The American Academy of Pediatrics is out with new guidelines on ADHD that some hoped would boost the role of behavioral interventions before medications. But the AAP stuck by its recommendation that children 6 and older should be given medicine combined with therapy after diagnosis.
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain — when prescribed in low doses. But few doctors or patients seem to know about it.
The latest technology makes managing Type 1 diabetes much easier. But managing insurance company rules for the supplies is a big obstacle for some patients.
The Austin City Council is setting aside $150,000 in city funds to help local women seeking an abortion pay for related costs, such as transportation or child care.
An average of three people a day died of opioid overdose in Philadelphia in 2018. But efforts to combat the crisis with a supervised injection site could be stymied by “the crackhouse statute,” a portion of federal law meant to protect neighborhoods during the crack epidemic of the 1980s.
In Utah, 85% of deaths from firearms are suicides. To help people who might be vulnerable, outreach workers are discussing suicide prevention at gun shows and firearms classes.
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
MDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
It can be difficult to get a prescription for buprenorphine, one of the gold standards for treating opioid use disorder. And not all pharmacies stock the drug.
At a camp for kids in Nashville, physical therapists use “constraint-induced movement therapy.” It makes life tougher, temporarily, in hopes of strengthening the campers’ ability to navigate the world.
Tennessee's innovative Medicaid program is offering bonuses to mental health providers who help make sure their Medicaid patients get preventive help and treatment for physical ailments, too.
Patients with Type 2 diabetes are often steered toward medicine or insulin treatment. But with additional support, it’s possible to use diet and exercise to control blood sugar. The rising price of insulin drives patients to lower their dependence on the medicine.
Some physicians say connecting the consequences of climate change — heat waves, more pollen and longer allergy seasons — to health helps them better care for patients.
Oklahoma is seeking $17 billion in damages from Johnson & Johnson, the pharmaceutical giant. After a seven-week trial, a judge will decide if the opioid drugmaker is liable and if so, for how much.
© 2026 KFF